title: PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.
authors.affiliation: Gastroenterology and Digestive Oncology, CHU Avicenne, APHP, Bobigny, France. Electronic address: thomas.aparicio@avc.aphp.fr.
authors.forename: Thomas
authors.initials: T
authors.lastname: Aparicio
authors.affiliation: Oncology, Centre Antoine Lacassagne, Nice, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Francois
authors.affiliation: Oncogeriatry, ICM Val d'Aurelle, Montpellier, France.
authors.forename: Laurence
authors.initials: L
authors.lastname: Cristol-Dalstein
authors.affiliation: Oncology, CH Senlis, Senlis, France.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Carola
authors.affiliation: Fédération Francophone de Cancérologie Digestive, Burgundy University, INSERM U866, Dijon, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Maillard
authors.affiliation: Geriatry, CHU Henri Mondor, APHP, Créteil, France.
authors.forename: Elena
authors.initials: E
authors.lastname: Paillaud
authors.affiliation: Geriatry, Centre Gérontologique Départemental, Marseille, France.
authors.forename: Frédérique
authors.initials: F
authors.lastname: Retornaz
authors.affiliation: Gastroenterology, CH de la Roche sur Yon, La Roche sur Yon, France.
authors.forename: Roger
authors.initials: R
authors.lastname: Faroux
authors.affiliation: Oncology, CHU Saint-Antoine, APHP, Paris, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: André
authors.affiliation: Fédération Francophone de Cancérologie Digestive, Burgundy University, INSERM U866, Dijon, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Bedenne
authors.affiliation: Hepato-Gastroenterology and Digestive Oncology, CHU La Timone, APHM, Marseille, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Seitz
mesh_terms: D000203:Activities of Daily Living; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013505:Digestive System Surgical Procedures; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010071:Oxaloacetates; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D010071:Oxaloacetates; D003841:Deoxycytidine; D000069287:Capecitabine; D002955:Leucovorin; D005472:Fluorouracil